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Background: The English National Health Service’s (NHS) Stop Smoking Services (SSSs) constitute one of the most
highly developed behavioural support programmes in the world. However, there is significant variation in success
rates across the approximately 150 services, some of which may be due to variation in practice. This study aimed to
assess these differences in practice.
Methods: Two online surveys were administered. All commissioners (people who purchase services for the NHS)
and managers (those who run the services) of NHS SSSs in England were invited to participate. Items included
details of current practices and services provided, what informed the commissioning of SSSs, what targets were
included within service specifications and whether the types of treatment model to be delivered were specified.
Results: Both surveys had a response rate of 35%, with 50 commissioners and 58 managers participating. There
were no significant differences between the characteristics of the Primary Care Trusts (PCTs) from which
commissioners and managers responded to this survey and those PCTs from which there was no response.
Managers reported that the treatment model most frequently offered by SSSs was one-to-one (98%). A total of
16% of managers reported that some approved medications were not available as first-line treatments. Just over
one third (38%) of commissioners reported consulting national guidelines or best evidence to inform local
commissioning. Almost one third (30%) of commissioners reported that they specified the types of stop smoking
interventions to be delivered by the providers.
Conclusions: A substantial part of commissioning of Stop Smoking Services in England appears to take place
without adequate consultation of evidence-based guidelines or specification of the service to be provided.
This may account for at least some of the variation in success rates.Background
In 1999, the UK government’s tobacco control strategy,
published in the White Paper ‘Smoking Kills’[1], estab-
lished the treatment of smokers as an integral part of
the effort to reduce smoking prevalence [2]. This led to
the formation of the English National Health Service’s
(NHS) Stop Smoking Services (SSSs). The SSSs were a* Correspondence: mairtin.mcdermott@gmail.com
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distribution, and reproduction in any mediumworld first and have come to be considered the ‘blue-
print’ for smoking cessation programmes throughout the
world. Each offers smokers a combination of evidence-
based behavioural and pharmacological treatments paid
for or subsidised through taxation. The SSSs have been
shown to be both effective [3,4] and cost-effective [5] and
have treated over three million smokers thus far [6,7].
Each SSS is organised independently within its local
Primary Care Trust (PCT), of which there were 152 at
the time the current study was conducted. PCTs are orga-
nisations currently responsible for identifying local prior-
ities and commissioning healthcare, including smoking
cessation, to serve the needs of their local populationntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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their practices as appropriate to meet local priorities and
targets, with the expectation they will reflect evidence-
based guidelines from national bodies such as the
National Institute for Health and Clinical Excellence
(NICE) [5] and the Department of Health (DoH) [6].
A process is normally followed when commissioning
SSSs that includes the identification of local need using
a range of qualitative and quantitative data, followed
by an analysis of how current service provision meets
that need. Priorities are then determined which would
inform service specifications and performance indica-
tors, against which providers would be performance
managed. Whilst such processes may allow services to
be responsive to local needs, they may also have contrib-
uted to a drift away from the evidence-base. Initially,
it was recommended by DoH that the primary stop
smoking intervention offered to smokers should com-
prise group support plus nicotine replacement therapy
(NRT), with weekly meetings covering six weeks. The
provision of one-to-one support was also specified where
appropriate such as in cases where smokers could or
would not attend groups [8]. However, it was found
that within a few years of their establishment SSSs were
increasingly providing one-to-one sessions [8]. By 2009/
2010, only 6% of smokers setting a quit date with the
services did so in a group [9]. Variability in practice may
also have contributed to the wide variation in success
rates across SSSs. In 2009/2010 four-week biochemically
validated quit rates ranged from 3–58%, with an average
of 34% [9]. Rates of biochemical validation (by expired
air carbon monoxide) provide explanation for some of
this variation, yet even when self-reported (non-verified)
quits are considered, the variation remains wide, from
31–70%, with an average of 49% [9].
Current guidelines recommend that smokers should
have a choice between a number of different pharmaco-
logical and behavioural interventions, whilst acknowledg-
ing that there is evidence of superior efficacy for some.
Three medications with evidence of effectiveness are
recommended: Nicotine Replacement Therapy (NRT),
bupropion (ZybanW) and varenicline (ChampixW in the
UK and ChantixW in the USA). There is evidence of
superiority of varenicline or combination NRT (i.e. sim-
ultaneously using two different types of NRT) over other
forms of pharmacology or no medication in both clinical
trials [10-12] and routine clinical practice [13]. Guide-
lines also recommend that medication is used in combin-
ation with behavioural support, usually in the form of
individual counselling or in groups, both of which are also
of proven efficacy in clinical trials [14,15], with evidence
from routine clinical practice indicating that group treat-
ment is more effective than one-to-one support [13,16,17].
The ability of SSSs to deliver high quality evidence-basedinterventions also depends on their stop smoking practi-
tioners (SSPs) being trained to a minimum standard and
being able to demonstrate and maintain the knowledge
and skills for effective job performance. Current guidelines
also recommend that interventions should be delivered by
practitioners who have had training and supervision that
complies with the NHS Centre for Smoking Cessation and
Training (NCSCT) Training Standard [18].
However little is known, either about the extent to
which these guidelines are adhered to in practice, or
about the processes determining how they are applied.
The surveys reported in this paper were carried out as
part of a programme of research conducted at the NHS
Centre for Smoking Cessation and Training (NCSCT).
One aim of the NCSCT is to establish what constitutes
best practice in treatment to aid smoking cessation, and
to develop and implement assessment and training to
ensure that all practitioners possess the competences ne-
cessary to deliver effective interventions (see www.ncsct.
co.uk). The aim of the current study, therefore, was to
describe the current practices and experiences of com-
missioners (i.e. those individuals who are responsible for
specifying and commissioning services to meet local
need and monitoring performance of providers) and
managers (i.e. those responsible for the day to day plan-
ning and delivery of SSSs) to identify possible factors
within the contracting of services that could account for
the variation in clinical outcome across England and to
investigate any association between these factors and
quit rates at commissioned SSSs.
Methods
Study design
Two online surveys were administered.
Participants and survey administration
Both surveys were available via a hyperlink sent out in
an electronic flier to all commissioners and managers of
SSSs in England. The NCSCT maintains databases of
commissioners and managers of SSSs and this informa-
tion was verified prior to launching the 2010 survey.
Reminders were sent at 10 and 20 days after the initial
contact, with a final reminder sent three days preceding
the survey’s close. The commissioners’ survey was open
between 22nd November and December 24th 2010. The
managers’ survey was open between 26th November and
December 24th 2010. The current study was classed as a
service evaluation of the current SSSs by the University
College London Research Ethics Committee and so was
exempt from ethical review.
Measures
The commissioners’ survey contained 28 items covering
a range of topics (see Additional file 1: Appendix A).
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and employment details. Following this, the survey asked
about the commissioning of stop smoking services, spe-
cifically whether commissioning was informed by their
PCT’s priorities, what targets they included within their
service specifications, whether they took various ele-
ments of support into account in their commissioning
framework and whether they specified the types of treat-
ment models to be delivered by providers. We also asked
whether service specifications included the availability of
all NICE-recommended medications as first-line treat-
ments, and the level of training that practitioners were
expected to undertake.
Managers completed a 29-item questionnaire survey
(see Additional file 1: Appendix B) which also first asked
for contact, basic demographic and employment details.
Items then covered commissioning, specifically the tar-
gets commissioners include within their service specifi-
cations, whether commissioners specify the settings or
treatment models they should run and managers’ rela-
tionship with their commissioner. Items were also asked
regarding the services provided by managers and the set-
tings in which their services were provided.
A combination of closed and open questions was used.
Where respondents were presented with a range of
categories to choose from, an ‘other’ option was also
included in order to invite the widest range of responses.
Drafts of the questionnaire were completed by NCSCT
personnel (including a current commissioner, ex-SSS
manager and two practitioners) for the purposes of
refinement prior to launching online.
Both commissioners and managers were asked to re-
port their employing PCT. This was then used to link
survey responses to data characterising the area in which
their PCT is located (Index of Multiple Deprivation
(IMD) [19]) and outcome and throughput data for the
local SSS (self-reported and CO-validated quit rates,
and number of smokers setting a quit date). The IMD is
an overall, continuous measure of multiple deprivation
experienced by people living in an area and is calcul-
ated by combining scores from seven distinct domains:
Income Deprivation, Employment Deprivation, Health
Deprivation and Disability, Education Skills and Training
Deprivation, Barriers to Housing and Services, Living
Environment Deprivation, and Crime [19]. SSS data was
taken from official NHS Stop Smoking Service statistics
collected between April 2010 and March 2011 [7].
Procedure
In total, 68 responses were recorded to the commis-
sioners’ survey. Of these, nine contained no data and
four supplied contact details only, these entries were all
excluded. Three commissioners had one duplicate entry
and one commissioner had two duplicate entries; inthese cases only the most complete set of answers
was retained. For the managers’ survey, a total of 85
responses were recorded. Of these nine did not contain
any data and 11 supplied contact details only, these
entries were excluded. Five managers had one duplicate
entry and one manager had two duplicate entries, only
the most complete set of answers was retained. There-
fore 50 commissioners (effective response rate = 35.2%,
50/142) and 58 managers (effective response rate =
35.4%, 58/164) completed the survey and it is on this
data that the findings are reported.Data analysis
Data were transferred to SPSS (Version 14) where they
were anonymised, coded and analysed. Basic descriptive
statistics were used to analyse participants’ responses.
Rates of missing data varied between 0% and 24% for
commissioners’ responses and 0% and 28% for managers.
No attempt was made to estimate missing values. Respon-
dents’ free-text responses were analysed using a content
analysis approach whereby text was analysed by looking at
the frequency of matching responses and converted into
categorical variables for analysis. Categorical variables
were analysed using basic descriptive statistics. Differences
between responding and non-responding PCTs in abstin-
ence rates, service throughput and IMD score were
investigated using independent samples t-tests, as were
differences in SSS abstinence rates.Results
Respondent characteristics
Commissioner and manager demographic and employ-
ment details and details of their PCTs can be seen in
Table 1. A total of 23 PCTs provided data from both
commissioner and manager.
The PCTs from which the samples of commissioners
and managers participating in the current study were
drawn did not differ from those who did not participate
in a number of important variables. There were no dif-
ferences between PCTs with participating commissioners
and those where commissioners did not participate, in
self-reported (responder mean=50.1%, vs. non-responder
mean=49.2%, t(150) =−0.63, p = .53) or CO-validated quit
rates (35.9% vs. 34.5%, t(150) =−0.82, p = .41), number
setting a quit date at the SSS (5764.5 vs. 5073.95,
t(150) =−1.38, p = .17) and PCT IMD score (24.1 vs.
23.4, t(150) =−0.48, p = .63). Similarly, there were no dif-
ferences between PCTs with responding managers and
those where managers did not participate in self-reported
(responder mean= 48.0%, vs. non-responder mean=
50.3%, t(150) = 1.78, p = .08) or CO-validated quit rates
(33.7%, vs. 35.7, t(150) = 1.19, p = .24), number setting a
quit date at the SSS (5527.9 vs. 5158.3, t(150) =−0.76,
Table 1 Commissioner and manager demographic, employment and PCT/SSS-level details
Commissioners (n = 50) a Managers (n = 58) a
Individual-level characteristics
Gender Female: %(n) 74 (37) 78 (35)
Mean length of time commissioning health
services (months)
Mean (SD, Range) 44.1 36.2, 6–180 -
Mean length of time commissioning/managing
stop smoking services (months)
Mean (SD, Range) 39.6 (33.4, 3–132) 44.8 (37.15, 6–144)
Is commissioning/managing stop smoking
services your sole responsibility?
Yes: % (n) 14 (5) 24 (14)
% of current role spent commissioning/managing
stop smoking services
Mean (SD, Range) 41.9 (27.1, 5–100) 83.4 (22.7, 20–100)
N other services commissioned/managed Mean (SD, Range) 2.9 (1.4, 1–6) 1.6 (0.7, 1–3)
N WTE ‘Specialist’ SSPs Mean (SD, Range) - 6.9 (5.8, 0–30)
N active community SSPs Mean (SD, Range) - 118.3 (95.3, 0–320)
PCT-level characteristics (n = 48) b (n = 55) b
Self-reported quit rate Mean % (SD, Range) 50.1 (8.6, 32.8–68.9) 48.0 (8.7, 29.5–68.9)
CO-validated quit rate Mean % (SD, Range) 35.9 (8.8, 14.8–56.6) 33.7 (10.6, 4.8–56.6)
Number of smokers setting a quit date Mean (SD, Range) 5764.5 (3212.4, 1619–16858) 5527.9 (2590.7, 1619–14515)
IMD Score c Mean (SD, Range) 24.1 (8.8, 11.3–43.5) 25.2 (9.5, 10.0–43.5)
N setting a quit date per WTE specialist SSP Mean (SD, Range) 1172.3 (941.1, 275.2–4568.0)
N setting a quit date per ‘active’ community SSP Mean (SD, Range) 232.9 (763.0, 16.4–4568.0)
a % may not add up to 100% due to rounding and missing data.
b Some PCTs had multiple responding commissioners/managers.
c Higher scores indicate greater deprivation.
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Managers reported employing an average of 6.9 (SD=
5.8, range = 0–30) Whole Time Equivalent (WTE) ‘Spe-
cialist’ SSPs (i.e. SSPs employed directly by the SSS
specifically to deliver stop smoking interventions). In
addition, 84% of managers (n = 48) stated that their SSS
was responsible for the support or performance manage-
ment of ‘Community’ SSPs (i.e. SSPs, who deliver sup-
port for the SSS as part of or in addition to their main
role, typically as practice nurses or community pharma-
cists), with 245 (SD= 335.0, range = 1–2000, median =
140) community SSPs being performance managed on
average. Managers estimated that 68% (SD= 23.5, Range
0–100) of these other practitioners were ‘active’, which
was defined as having supported over five clients in the
last six months and returned monitoring forms (i.e. data
on the numbers of smokers entering treatment, setting a
quit date and their outcome (e.g. quit, relapsed, lost to
follow-up). Based on this estimate, the mean number of
‘active’ community SSPs can be seen in Table 1.
Commissioning of stop smoking services
Figure 1 gives details for targets commissioners include
within their service specifications and managers had
within the service specifications for their service, restricted
to those commissioners and managers who responded
from the same PCT. The majority (88%, n=44) ofmanagers said that they had regular arranged meetings
with their commissioner and 94% (n=44) said that they
had a good relationship with their commissioner.
The vast majority, 92% (n = 44) of commissioners said
that SSSs were commissioned from an NHS provider
organisation and 49% (n = 23) that SSSs were commis-
sioned from a single provider organisation. A total of
78% (n = 35) of commissioners stated that the commis-
sioning of SSSs was based on a local needs assessment.
In free-text responses, the most frequently cited source
of information contained in the assessment was smoking
prevalence (67%, n = 22), followed by information on
demographics (36%, n = 12), mortality and morbidity
(30%, n = 10) and economic deprivation (30%, n = 10).
When asked what informed local commissioning beyond
the local needs assessment, again using free-text
responses, the most frequently cited source of informa-
tion was best evidence or national guidance (e.g. from
DoH, NICE, 38%, n = 15), user experience (28%, n = 11)
followed by the annual SSS report or other survey data
(15%, n = 6) and local knowledge (13%, n = 5).
Services provided
A total of 70% (n = 33) of commissioners said that they
had developed a commissioning framework that takes
various types of stop smoking interventions (e.g. very
brief advice through to intensive support) and different
settings for provision into account. The same proportion
Figure 1 Targets included by commissioners within their service specifications and within managers’ service specifications for their
service a (Figure 1 (Revised).doc).
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fied the types of stop smoking interventions to be deliv-
ered by the providers.
In contrast, only 24% (n = 13) of managers stated that
the commissioner of the SSS specified the settings in
which the service should run and 36% (n = 19) stated
that the commissioner of their SSS specified the types of
stop smoking interventions to be offered. A total of 17%
(n = 8) of commissioners and 15% (n = 7) of managers
said that not all recommended medications (i.e. NRT,
bupropion & varenicline) were available as first-line
treatments. Table 2 shows the treatment models man-
agers’ report their services offer, the settings in which
their treatments run, and the availability of medications
at their SSS.
The majority (80%, n = 36) of commissioners reported
that service specifications for smoking stated the level of
training that practitioners are expected to achieve. The
most frequently cited level to be achieved was in line
with NCSCT guidelines [18] (or HDA standard as was
required formerly [20]) (53%, n = 17).
Discussion
There was little evidence of commissioners routinely
referring to evidence-based guidelines when commis-
sioning services. Whilst an explicit question was not
asked regarding references to guidelines in service speci-
fications, based on free-text responses just over one
third of commissioners mentioned that best evidence orguidelines from national bodies such as NICE or the
Department of Health were used to inform the commis-
sioning of local SSSs. This is in spite of commissioners
being prompted to refer to the evidence base within the
NHS Standard Community Services Contract [21].
It is possible, in recognition of the knowledge and
experience of SSS managers that many commissioners
would not explicitly specify that stop smoking interven-
tions should be based on current evidence, focussing
instead on the targets to be met, with the expectation
that guidelines would be adhered to. There may also be a
failure of communication between commissioners and
managers as to the content of service specifications. Com-
missioners and managers from the same PCTs did not
appear to be in agreement over the targets reported in
service specifications. Although this may be also be due
to only managers from ‘core’ Stop Smoking Services hav-
ing been invited to participate, whereas commissioners
may have responded taking into account multiple service
providers, such as those deliver smoking cessation locally,
e.g. services commissioned from Primary Care providers
such as GP practices or pharmacists. In addition over two
thirds of commissioners reported that they specified the
types of stop smoking interventions to be delivered by the
providers, whilst only one third of managers indicated
that this was the case. It is possible that managers might
have interpreted the word ‘specify’ as implying that the
requirements of commissioners are stated explicitly with-
out consultation. Given the vast majority of managers
Table 2 Treatments models offered and settings in which
services run according to SSS managers (n = 58)
Treatment models offered a % (n)
One-to-one appointments 98 (57)
Telephone advice/counselling 90 (52)
Home visits 83 (48)
Self-help materials 79 (46)
One-to-one drop-in sessions 78 (45)
Closed group programmes 69 (40)
Rolling group programmes 69 (40)
Peer led sessions 14 (8)
Settings in which services run a b
Primary care settings 93 (54)
Workplaces 90 (52)
Secondary health care settings (e.g. hospitals) 88 (51)
Voluntary sector/Local Authority premises 86 (50)
Pharmacies 86 (50)
Commercially rented venues 60 (35)
Central base exclusive to SSS 43 (25)
Availability of medications (first line)
Nicotine Replacement Therapy 100 (49)
Varenicline (Champix) 86 (42)
Bupropion (Zyban) 84 (41)
All medications 84 (41)
a Participants could choose more than one category.
b Groups can be ‘open (rolling)’ or ‘closed’; open groups are open to new
members at each session, i.e. individuals within the same group will be at
different points in their quit attempt and have different quit dates. A closed
group in contrast is a group in which all members start their quit attempt
together and new members cannot join after the first meeting. Drop-ins differ
from one-to-one support in that they operate without fixed appointments and
number and timings of sessions are less fixed (3).
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sioner, this might explain why so few endorsed this item.
However, the NHS Standard Community Services Con-
tract [21] does prompt specification of service delivery,
and so whatever the decision making process, commis-
sioners will either specify the types of intervention to be
included in the service provided or not, and so this dis-
crepancy remains an important one to note.
Given the commissioning of SSSs was not the sole
responsibility for the vast majority of respondents; com-
missioners may lack sufficient time within their role to
provide large amounts of detail on how services should
be managed. The mean length of time spent commis-
sioning health services was also greater than that spent
commissioning stop smoking services, meaning that
many of these commissioners may have had smoking
cessation added to a broader portfolio of services to
commission, and may not have sufficiently high levels of
expertise to make specific recommendations.
Despite these issues, the majority of managers indi-
cated that the treatments and services they offered werein line with evidence based guidelines. The most com-
monly offered treatment model was one-to-one, which is
in line with SSS statistics showing that most smokers set
a quit date using this model in 2009/2010 [9]. Although
systematic review evidence indicates that one-to-one
support for smoking cessation is of proven efficacy when
compared with self-help interventions, group interven-
tions have shown a bigger effect [13-15] and their super-
ior efficacy is reported in current SSS guidelines [6].
Although only 2% of smokers set a quit date using a
closed group programme in 2009/2010 [9], over two
thirds of managers indicated that they offered this treat-
ment model. Previous research [8] has suggested that
the shift towards one-to-one services was largely due to
client preference for one-to-one services, and this
may well account for some of the discrepancy between
the availability and uptake of other, more effective treat-
ment models such as closed groups. Further examination
of why so few smokers take up this treatment option
despite its availability may be worthy of further attention.
The majority of SSS managers also indicated that all
NICE-approved medications (NRT, bupropion & vareni-
cline) were available as first-line treatments. Improved
treatment outcomes could still be achieved, however,
were evidence-based guidelines adhered to more strin-
gently. Based on managers’ reports of the availability of
the most effective treatments and current rates of uptake
by clients and effectiveness at NHS SSSs [9], had 100%
of managers made closed groups available to SSS atten-
dees in 2009/2010 it could have led to 4,610 extra quit-
ters that year. Similarly, had 100% of SSS managers
made varenicline available it could have resulted in
17,249 additional quitters.
Future research
The current study suggests several avenues for further
research. Of primary importance is to explore managers’
and commissioners’ perceptions of whose responsibility
it is to ensure that evidence-based guidelines are applied
in practice. Future research questions could also explore
the gaps between managers’ reported availability of the
most effective treatments, i.e. closed groups, and the
observed uptake in SSS statistics [9]. As well as encour-
aging SSS managers to increase availability of these
interventions it may also be important to further exam-
ine why so few smokers take up this treatment option
despite its availability and to intervene if necessary. For
commissioners, future research could include analysis of
SSS specifications, including their content and the level
of detail included, investigation of commissioners’ per-
spectives on their roles and responsibilities, and com-
missioner confidence in whether SSS are compliant with
service specifications and whether this confidence is
reflected in the level of active involvement they have
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investigate whether these aspects of commissioners’ and
managers’ practices are associated with abstinence rates.Strengths & limitations
The response rate for both surveys was 35%, which
although lower than previous research of SSS managers
[22,23] is comparable with the average response rate of
40% reported by Cook and colleagues [24] in a meta-
analysis of 68 studies based on online surveys. The PCTs
from which commissioners and managers responded did
not, however, appear to differ significantly from those
PCTs from which no one responded both in terms
of local deprivation, or SSS outcome or throughput.
Another limitation is the amount of missing data in the
survey, which was as much as 28% for some items.
Mandatory fields could be used to minimise this in
future surveys. However, conversely, one strength of the
survey was the inclusion of multiple free-text response
options, meaning that respondents were not constrained
by the options pre-determined by the researchers using
fixed, tick-box questions, allowing them more freedom
of expression.Conclusions
Whilst the majority of managers indicated that the treat-
ments and services they offered were in line with evi-
dence based guidelines, treatment outcomes for smokers
could be improved were guidelines adhered to more
stringently. A substantial part of commissioning of Stop
Smoking Services in England appears to take place with-
out adequate consultation of evidence-based guidelines
or specification of the service to be provided. Although
commissioners may allow SSS managers the autonomy
to configure their own services in the expectation that
guidelines are adhered to, the current surveys indicate
that they may need to clearly and explicitly refer to the
evidence base in service specifications to ensure that
smokers have access to the most effective interventions.
The current failure to achieve this level of specifica-
tion may account for at least some of the variation in
success rates. Future research should attempt to ascer-
tain whose responsibility commissioners and managers
perceive it is to ensure that guidelines for best practice
are adhered to. Work could then be conducted to estab-
lish a clear procedure for the translation of the evidence
base into practice.Additional file
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